OALBB0503 | Increasing second-line antiretroviral therapy options for children with HIV in Africa: week-96 efficacy and safety results of the CHAPAS-4 randomised trial | Oral abstract session with live Q&A | Antiretroviral therapies and clinical issues in infants, children and adolescents |
OALBB0504 | Risks of hypertension with first-line dolutegravir (DTG) and tenofovir alafenamide (TAF) in the NAMSAL and ADVANCE trials | Oral abstract session with live Q&A | Clinical complications of HIV and antiretroviral therapy |
OALBB0505 | Impact of INSTI and TAF-related BMI changes and risk on hypertension and dyslipidemia in RESPOND | Oral abstract session with live Q&A | Clinical complications of HIV and antiretroviral therapy |
OALBC0602 | Should social network testing be offered as an additional HIV testing approach? A GRADE systematic review and meta-analysis | Oral abstract session with live Q&A | HIV testing |
OALBC0603 | Acceptability of CAB-LA in cisgender female adolescents in South Africa, Uganda, and Zimbabwe (HPTN 084-01) | Oral abstract session with live Q&A | Population-specific interventions for HIV prevention |
OALBC0604 | High in-hospital mortality in SARS-CoV-2 infected patients living with HIV during pre-Delta, Delta and Omicron variant waves: finding from the WHO Global Clinical Platform for COVID-19 | Oral abstract session with live Q&A | Epidemiology of COVID-19 |
OALBC0605 | An HIV Prevention model focused on key populations alone will not end HIV/AIDS in Thailand by 2030 | Oral abstract session with live Q&A | Population-specific interventions for HIV prevention |
OALBD0602 | “It was just the most horrible experience of my life” understanding social and care experiences during and after mpox illness: qualitative accounts of people diagnosed and close contacts in Australia | Oral abstract session with live Q&A | Key populations and other vulnerable populations: Behavioural, social and cultural issues and contexts |
OALBD0603 | Using client-centered models to sustain HIV service delivery to key populations in Uganda | Oral abstract session with live Q&A | Key populations and other vulnerable populations: Behavioural, social and cultural issues and contexts |
OALBD0604 | Bespoke strategies for coping with addiction and HIV during and after COVID-19 crisis by prisoners with comorbid HIV and a history of opioid use disorder in Kyrgyzstan | Oral abstract session with live Q&A | Social and behavioural aspects and approaches to COVID-19 |